REFERENCES
- Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food
and Drug Administration-approval study with a continuous flow left
ventricular assist device as a bridge to heart transplantation: a
prospective study using the INTER- MACS (Interagency Registry for
Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;
57:1890-1898.
- Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right
ventricular failure risk score: a pre-operative tool for assessing the
risk of right ventricular failure in left ventricular assist device
candidates. J Am Coll Cardiol. 2008; 51:2163-2172.
- Lampert BC, Teuteberg JJ. Right ventricular failure after left
ventricular assist devices. J Heart Lung Transplant. 2015;34:
1123-1130.
- Dang NC, Topkara VK, Mercando M, et al. Right heart fail- ure after
left ventricular assist device implantation in patients with chronic
congestive heart failure. J Heart Lung Transplant. 2006; 25:1-6.
- Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure
in patients with the HeartMate II continuous-flow left ventricular
assist device: incidence, risk factors, and effect on outcomes. J
Thorac Cardiovasc Surg. 2010; 139:1316-1324.
- Fitzpatrick JR, Frederick JR, Hsu VM, et al. Risk score derived from
pre-operative data analysis predicts the need for biventricular
mechanical circulatory support. J Heart Lung Transplant. 2008;
27:1286-1292.
- Kang G, Ha R, Banerjee D. Pulmonary artery pulsatility index predicts
right ventricular failure after left ventricular assist device
implantation. J Heart Lung Transplant. 2016;35: 67-73.
- Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et
al. The 2013 International Society for Heart and Lung Transplantation
Guidelines for mechanical circulatory support: executive summary. J
Heart Lung Transplant 2013;32(2):157–87.
- Nguyen AB, Uriel N, Adatya S. New challenges in the treatment of
patients with left ventricular support: LVAD thrombosis. Curr Heart
Fail Rep 2016;13 (6):302–9
- Uriel N, Morrison KA, Garan AR, Kato TS, Yuzefpolskaya M, Latif F, et
al. Development of a novel echocardiography ramp test for speed
optimization and diagnosis of device thrombosis in continuous flow
left ventricular assist devices: the Columbia ramp study. J Am Coll
Cardiol 2012;60(18):1764–75.
- Uriel N, Levin AP, Sayer GT, Mody KP, Thomas SS, Adatya S, et al. Left
ventricular decompression during speed optimization ramps in patients
supported by continuous-flow left ventricular assist devices:
device-specific performance characteristics and impact on diagnostic
algorithms. J Card Fail 2015;21(10):785–91.
- Uriel N, Sayer G, Addetia K, Fedson S, Kim GH, Rodgers D, et al.
Hemodynamic ramp tests in patients with left ventricular assist
devices. JACC Heart Fail 2016; 4(3):208–17.
- Suwa H, Seguchi O, Fujita T, Murata Y, Hieda M, Watanabe T, et al.
Paracorporeal ventricular assist device as a bridge to transplant
candidacy in the era of implantable continuous-flow ventricular assist
device. J Artif Organs 2014;17 (1):16–22.
- Imamura T, Burkhoff D, Rodgers D, Atadya S, Sarswat N, Kim G, et al.
Repeated ramp tests on stable LVAD patients reveal patient-specific
hemodynamic fingerprint. ASAIO J 2017. http://dx.doi.org/10.1097/MAT.
- Jung MH, Gustafsson F, Houston B, Russell SD. Ramp study hemodynamics,
functional capacity, and outcome in heart failure patients with
continuous- flow left ventricular assist devices. ASAIO J
2016;62(4):442–6.
- Couperus LE, Delgado V, Khidir MJH, Vester MPM, Palmen M, Fiocco M, et
al. Pump speed optimization in stable patients with a left ventricular
assist device. ASAIO J 2017;63(3):266–72.
- Burke MA, Givertz MM. Assessment and management of heart failure after
left ventricular assist device implantation. Circulation 2014;129:
1161-6.
- Fitzpatrick JR III, Frederick JR, Hiesinger W, et al. Early planned
institution of biventricular mechanical circulatory support results in
improved outcomes compared with delayed conversion of a left
ventricular assist device to a biventricular assist device. J Thorac
Cardiovasc Surg 2009;137:971-7.
- Koji Takeda, MD, PhD,a Hiroo Takayama, MD, PhD,a Paolo C. Colombo,
MD,b Melana Yuzefpolskaya, MD,b Shinichi Fukuhara, MD,a Jiho Han,
BS,acPaul Kurlansky, MD,a Donna M. Mancini, MD,b and Yoshifumi Naka,
MD, PhDa Incidence and clinical significance of late right heart
failure during continuous-flow left ventricular assist device support.
J Heart Lung Transplant 2015; 34:1024–1032
- Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure
in patients with the HeartMate II continuous-flow left ventricular
assist device: incidence, risk factors, and effect on outcomes. J
Thorac Cardiovasc Surg 2010; 139:1316-24.
- Lietz K, Long JW, Kfoury AG, et al : outcomes of left
ventricular assist device implantation as destination therapy in the
post- REMATCH era: Implications for patient selection.Circulation 116: 497–505, 2007.
- Topilsky y, Hasin T, oh JK, et al : Echocardiographic variables
after left ventricular assist device implantation associated with
adverse outcome. Circ Cardiovasc Imaging 4: 648–661, 2011.
- Noor MR, Bowles C, banner NR: Relationship between pump speed and
exercise capacity during HeartMate II left ventricular assist device
support: Influence of residual left ventricular function. Eur J
Heart Fail 14: 613–620, 2012.
- Mudd Jo, Cuda JD, Halushka M, Soderlund KA, Conte JV, Russell SD:
Fusion of aortic valve commissures in patients supported by a
continuous axial flow left ventricular assist device. J Heart
Lung Transplant 27: 1269–1274, 2008.
- Uriel N, Takayama H, et al : prevalence of de novo aortic
insufficiency during long-term support with left ventricular assist
devices. J Heart Lung Transplant 29: 1172–1176, 2010.